Heart problems resolve in majority of kids with COVID inflammatory syndrome
Heart problems in children hospitalized with multisystem inflammatory syndrome (MIS-C)—an inflammatory condition triggered by COVID—were mostly gone within a few […]
A man in China has been hospitalized with the H5N6 strain of avian flu, which is one of several potentially […] (HealthDay)—Pandemic-related disruptions in routine childhood vaccine coverage occurred worldwide in 2020, with the highest disruptions seen in April 2020, according […] As Americans start packing bars and live venues once again in the age of mass COVID-19 vaccination — with many […] SYDNEY (Reuters) -Coronavirus cases in Australia spiked again on Thursday, despite a weeks-long lockdown, with authorities warning that infections would […] An interesting study led by scientists in the U.S. has recently revealed that the microbial community in the gut is […] LITTLE ROCK, Ark. — Public health researchers on Tuesday called the rapid rise in coronavirus cases and hospitalizations in Arkansas […] (HealthDay)—Giving a third dose of COVID-19 vaccines to immunocompromised adults will be up for discussion during a U.S. Centers for […] BBC Weather: Carol Kirkwood issues warning for 'extreme heat' We use your sign-up to provide content in ways you’ve consented […] NEW YORK (Reuters Health) – Donafenib, a novel multikinase inhibitor and a deuterated sorafenib derivative, significantly improved overall survival versus […]Health News
Chinese man hospitalized with H5N6 bird flu
Model estimates routine child vaccine doses missed during 2020
As COVID-19 surges again, what experts say about the millions of unvaccinated
Australia cautions COVID-19 cases to rise despite weeks-long lockdown
Dysbiosis in gut microbiota may cause severe secondary infection in COVID-19 patients
Researchers: Virus surge a 'raging forest fire' in Arkansas
CDC advisers to discuss third COVID-19 vaccine dose for immunocompromised
How to cool down: Four easy ways to cool down fast in a heatwave
Donafenib OS Better Than Sorafenib in Advanced Liver Cancer